<DOC>
	<DOCNO>NCT01092572</DOCNO>
	<brief_summary>Cystic fibrosis ( CF ) lethal genetic condition affect 30,000 child adult United States . Although CF management improve substantially past two decade , still cure patient CF die reach 50th birthday , largely due lung failure . There grow evidence excess lung blood inflammation occur response infection lung cause CF patient sicker . Simvastatin drug use low cholesterol , many researcher find drug may also treat blood lung inflammation . In study , determine whether simvastatin treat blood lung inflammation patient CF importantly determine whether make patient feel well well lung function .</brief_summary>
	<brief_title>Statins To Treat Adult Cystic Fibrosis</brief_title>
	<detailed_description>Study Objectives 1 . To determine effect 12 week 40 mg daily simvastatin general inflammatory molecule , IL-6 CRP blood CF patient . 2 . To determine effect simvastatin LPS-related pathway molecule blood . 3 . To determine effect simvastatin inflammatory pneumo-proteins blood . 4 . To determine exacerbation safety data statin preparation large phase III trial statin CF . Study Endpoints The primary endpoint quantitative change serum level CRP . Secondary endpoint include : 1. blood biomarkers IL6 , LPS relate protein , LPS , LBP , sCD14 EndoCAb , pneumoproteins , SPD CCL18 ; molecules TNF-α IL-1beta ; 2. change FEV1 12 week ; 3. exacerbation 12 week</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Patients provincial legal age majority British Columbia ( ≥19 year age ) ; 2 . Confirmed diagnosis CF base follow criterion : 1 . One clinical feature consistent CF phenotype 2 . A genotype identifiable class I II CFTR mutation 3 . Ability provide inform consent . 4 . Clinically stable enrollment assess treat physician . 5 . Ability comply medication use , study visit study procedure , spirometry , venipuncture . 1 . Allergy clinical reaction simvastatin . 2 . The follow abnormal lab value within last six month screen : AST/ALT &gt; 1.5 ULN , CK &gt; 1.5 ULN , eGFR &lt; 40ml/min/1.73m2 . 3 . Use intravenous antibiotic oral quinolones within 14 day screen . 4 . With exception Azithromycin use oral antibiotic include prophylactic antibiotic ( e.g. , augmentin , tetracycline , cloxacillin , cephalosporin , trimethoprim/sulfamethoxazole ) within 14 day screen . 5 . Initiation high dose ibuprofen , dornase alpha , hypertonic saline aerosolize antibiotic within 30 day screen . 6 . On medication know potential serious interaction simvastatin ( list page 10 protocol ) . 7 . Use systemic corticosteroid within 30 day screen . 8 . Investigational drug use within 30 day screen . 9 . Other major organ dysfunction exclude pancreatic dysfunction . 10 . History lung transplantation currently lung transplant list . 11 . Pregnant , breast feeding , postmenarche female , unwilling practice birth control participation study . 12 . Chronic user niacin , azole antifungal ( itraconazole , ketoconazole , voriconazole ) , telithromycin , fibric acid derivative , HIV protease inhibitor , amiodarone , digoxin and/or cyclosporine ( decrease risk statinrelated myotoxicity ) . 13 . Patients colonize infected Burkholderia cepacia complex exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>adult cystic fibrosis</keyword>
</DOC>